ENTXHIGH SIGNALRISK10-K

ENTX faces substantial doubt about its ability to continue as a going concern with cash resources projected to last only through mid-third quarter 2026.

The company's explicit going concern warning indicates severe liquidity constraints despite recent capital raising that substantially increased assets and equity. With revenue dropping significantly and operating losses expanding, ENTX faces an urgent need for additional financing within months.

Comparing 2026-03-27 vs 2025-03-28View on EDGAR →
FINANCIAL ANALYSIS

ENTX's balance sheet shows meaningful expansion in assets and equity, suggesting recent capital raising activity, though cash reserves declined modestly to $7.1M. Revenue fell substantially while R&D expenses grew notably and operating losses expanded to $11.5M. The overall picture reveals a development-stage company burning through capital at an accelerating pace with minimal revenue generation.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+87.3%
$1.2M$2.2M

Current liabilities surged 87.3% — significant near-term obligations; verify ability to meet short-term debt.

Revenue
P&L
-76.8%
$181K$42K

Revenue declined 76.8% — significant demand weakness or market share loss warrants investigation.

Current Assets
Balance Sheet
+70.5%
$9.0M$15.3M

Current assets grew 70.5% — improving short-term liquidity or inventory/receivables build.

Total Assets
Balance Sheet
+70.3%
$9.4M$16.0M

Asset base grew 70.3% — expansion through organic growth, acquisitions, or capital deployment.

Stockholders Equity
Balance Sheet
+62.1%
$8.1M$13.1M

Equity base grew 62.1% — retained earnings accumulation or equity issuance strengthening the balance sheet.

R&D Expense
P&L
+33.5%
$4.5M$6.0M

R&D investment increased 33.5% — signals commitment to future product development, though near-term margin impact.

Operating Income
P&L
-20.3%
-$9.6M-$11.5M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Net Income
P&L
-19.9%
-$9.5M-$11.4M

Net income declined 19.9% — review whether driven by operations, interest costs, or non-recurring items.

Cash & Equivalents
Balance Sheet
-17.9%
$8.7M$7.1M

Cash decreased 17.9% — monitor burn rate and upcoming capital needs.

SG&A Expense
P&L
+17.1%
$340K$398K

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

LANGUAGE CHANGES
NEW — 2026-03-27
PRIOR — 2025-03-28
ADDED
- 1638097 - 2026 00-0000000 1 Other development expenses include materials and productions and others.
Other segment expenses include payroll and related expenses, share-based compensation, legal and audit and related fees and others.
0001638097 false FY Represents an amount less than one thousand U.S.
As of March 23, 2026, the registrant had 46,622,239 ordinary shares, par value NIS 0.0000769 per share ( Ordinary Shares ) outstanding.
The Company may seek to raise capital through debt or equity financings to or through other strategic initiatives.
+7 more — sign up free →
REMOVED
- 1638097 - 2025 Represents an amount less than one thousand U.S.
25% vest on the first anniversary of the date of grant and the remaining 75% of the options vest in twelve equal quarterly installments following the first anniversary of the grant date.
33.33% vest on the first anniversary of the date of grant and the remaining 66.67% of the options vest in eight equal quarterly installments following the first anniversary of the grant date.
As of March, 20, 2025, the registrant had 45,420,676 ordinary shares, par value NIS 0.0000769 per share ( Ordinary Shares ) outstanding.
corporations; and Security, political and economic instability in the Middle East may harm our business, including the duration and intensity of the ongoing Israel-Hamas War and its impact on our operations and workforce.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →